Trials / Completed
CompletedNCT03897595
Assess the Mid-term Performance of the Mpact Cup in Subjects Requiring Total Hip Arthroplasty
A Multi-centre, Prospective Post Marketing Surveillance Study to Assess Mid-term Performance of the Mpact Cup in Subjects Requiring Primary Total Hip Arthroplasty
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 187 (actual)
- Sponsor
- Medacta USA · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
Monitor the performance of the Mpact cup in the treatment of patients with hip joint disease requiring a total hip replacement.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MPact Cup | Quadra®-H, Quadra®-C, AMIStem®-H or AMIStem®-C femoral stem and Mpact® Acetabular hip system with CoCr Femoral Head or Ceramic MectaCer BIOLOX® Femoral Head |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2022-03-30
- Completion
- 2022-03-30
- First posted
- 2019-04-01
- Last updated
- 2023-06-18
Locations
5 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03897595. Inclusion in this directory is not an endorsement.